These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 8554682)
1. Plasma concentrations of type II phospholipase A2, cytokines and eicosanoids in patients with burns. Nakae H; Endo S; Inada K; Yamashita H; Yamada Y; Takakuwa T; Kasai T; Ogawa M; Uchida K Burns; 1995 Sep; 21(6):422-6. PubMed ID: 8554682 [TBL] [Abstract][Full Text] [Related]
2. Blood cytokine and complement levels in patients with sepsis. Takakuwa T; Endo S; Nakae H; Kikuchi M; Baba N; Inada K; Yoshida M Res Commun Chem Pathol Pharmacol; 1994 Jun; 84(3):291-300. PubMed ID: 7938903 [TBL] [Abstract][Full Text] [Related]
3. Plasma levels of type II phospholipase A2 and cytokines in patients with sepsis. Endo S; Inada K; Nakae H; Takakuwa T; Yamada Y; Suzuki T; Taniguchi S; Yoshida M; Ogawa M; Teraoka H Res Commun Mol Pathol Pharmacol; 1995 Dec; 90(3):413-21. PubMed ID: 8746487 [TBL] [Abstract][Full Text] [Related]
4. Relationship between plasma levels of type II phospholipase A2, PAF acetylhydrolase, endothelin-1, and thrombomodulin in patients with infected burns. Takakuwa T; Endo S; Nakae H; Yamada Y; Inada K; Yoshida M; Ogawa M; Uchida K Res Commun Mol Pathol Pharmacol; 1994 Dec; 86(3):335-40. PubMed ID: 7712109 [TBL] [Abstract][Full Text] [Related]
5. Relationships between plasma levels of type-II phospholipase A2, PAF-acetylhydrolase, leukotriene B4, complements, endothelin-1, and thrombomodulin in patients with sepsis. Takakuwa T; Endo S; Nakae H; Suzuki T; Inada K; Yoshida M; Ogawa M; Uchida K Res Commun Chem Pathol Pharmacol; 1994 Jun; 84(3):271-81. PubMed ID: 7938901 [TBL] [Abstract][Full Text] [Related]
6. Plasma levels of type II phospholipase A2 and nitrite/nitrate in patients with burns. Yamada Y; Endo S; Kamei Y; Minato T; Yokoyama M; Taniguchi S; Nakae H; Inada K; Ogawa M Burns; 1998 Sep; 24(6):513-7. PubMed ID: 9776089 [TBL] [Abstract][Full Text] [Related]
8. Local and systemic inflammatory mediator release in patients with acute and chronic posttraumatic osteomyelitis. Klosterhalfen B; Peters KM; Tons C; Hauptmann S; Klein CL; Kirkpatrick CJ J Trauma; 1996 Mar; 40(3):372-8. PubMed ID: 8601852 [TBL] [Abstract][Full Text] [Related]
9. Nitrite/nitrate (NOX) and type II phospholipase A2, leukotriene B4, and platelet-activating factor levels in patients with septic shock. Nakae H; Endo S; Inada K; Yaegashi Y; Takakuwa T; Yamada Y; Arakawa N; Suzuki T; Taniguchi S; Shimamura T; Ogawa M; Teraoka H Res Commun Mol Pathol Pharmacol; 1996 May; 92(2):131-9. PubMed ID: 8774066 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-1 mediates increased plasma levels of eicosanoids and cytokines in patients with sepsis syndrome. Slotman GJ; Friedman B; Brathwaite C; Mure AJ; Quinn JV; Shapiro E Shock; 1995 Nov; 4(5):318-23. PubMed ID: 8595517 [TBL] [Abstract][Full Text] [Related]
11. Unopposed interleukin-1 is necessary for increased plasma cytokine and eicosanoid levels to develop in severe sepsis. Slotman GJ; Quinn JV; Wry PC; Brathwaite CE; Friedman BM Ann Surg; 1997 Jul; 226(1):77-84. PubMed ID: 9242341 [TBL] [Abstract][Full Text] [Related]
12. Effects of phospholipases A2 from Vipera russelli snake venom on blood pressure, plasma prostacyclin level and renin activity in rats. Huang HC Toxicon; 1984; 22(2):253-64. PubMed ID: 6374970 [TBL] [Abstract][Full Text] [Related]
13. Plasma type II phospholipase A2 levels in patients with acute pancreatitis. Miura M; Endo S; Kaku LL; Inoue Y; Sato N; Wakabayshi G; Baba E; Katsuya H; Inada K; Sato S Res Commun Mol Pathol Pharmacol; 2001; 109(3-4):159-64. PubMed ID: 11758647 [TBL] [Abstract][Full Text] [Related]
14. Platelet-activating factor (PAF) acetylhydrolase activity, type II phospholipase A2, and cytokine levels in patients with sepsis. Endo S; Inada K; Yamashita H; Takakuwa T; Nakae H; Kasai T; Kikuchi M; Ogawa M; Uchida K; Yoshida M Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):289-95. PubMed ID: 8008978 [TBL] [Abstract][Full Text] [Related]
15. Secretory non-pancreatic phopholipase A2 in severe sepsis: relation to endotoxin, cytokines and thromboxane B2. Guidet B; Piot O; Masliah J; Barakett V; Maury E; Bereziat G; Offenstadt G Infection; 1996; 24(2):103-8. PubMed ID: 8740100 [TBL] [Abstract][Full Text] [Related]
16. Assessment of inflammatory cytokines, nitrate/nitrite, type II phospholipase A2, and soluble adhesion molecules in systemic inflammatory response syndrome. Takakuwa T; Endo S; Inada K; Kasai T; Yamada Y; Ogawa M Res Commun Mol Pathol Pharmacol; 1997 Oct; 98(1):43-52. PubMed ID: 9434314 [TBL] [Abstract][Full Text] [Related]
17. Concentrations of cytokines in plasma of patients with large burns: their relation to time after injury, burn size, inflammatory variables, infection, and outcome. Vindenes HA; Ulvestad E; Bjerknes R Eur J Surg; 1998 Sep; 164(9):647-56. PubMed ID: 9728783 [TBL] [Abstract][Full Text] [Related]
18. Phospholipase A2 is a circulating mediator in typhoid fever. Keuter M; Dharmana E; Kullberg BJ; Schalkwijk C; Gasem MH; Seuren L; Djokomoeljanto R; Dolmans WM; van den Bosch H; van der Meer JW J Infect Dis; 1995 Jul; 172(1):305-8. PubMed ID: 7797937 [TBL] [Abstract][Full Text] [Related]
19. PAF acetylhydrolase and arachidonic acid metabolite levels in patients with sepsis. Takakuwa T; Endo S; Nakae H; Kikichi M; Inada K; Yoshida M Res Commun Chem Pathol Pharmacol; 1994 Jun; 84(3):283-90. PubMed ID: 7938902 [TBL] [Abstract][Full Text] [Related]
20. Modulation of eicosanoid biosynthesis and inhibition of substrate availability for phospholipase A2 by a modified hexose sugar, amiprilose hydrochloride. Young MR Prostaglandins; 1990 Jul; 40(1):35-49. PubMed ID: 2167503 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]